🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Lwizyàn › New Orleans

Etid klinik pou Kansè (tout kalite) nan New Orleans, LA

12 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote New Orleans (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Care Access-Marrero, Marrero · 4 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Children's Hospital New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • University Medical Center New Orleans, New Orleans
  • Ochsner Baptist Medical Center, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Ochsner Health, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06657144

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Tulane University School of Medicine /ID# 251204, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Louisiana State University Health Sciences Center, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • Local Institution - 2116, New Orleans
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Galleri® in the Medicare Population.

Ap rekriteVolontè an sante akeyi
  • Ochsner Health Baptist, New Orleans
  • Ochsner Health Benson, New Orleans
  • Ochsner Health Westbank, Marrero · 4 mi lwen
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05673018

Caris Biorepository Research Protocol

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Tulane University, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Jan 21, 2026 · NCT01499394

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

Ap rekriteFaz 1
  • Ochsner Clinic Foundation, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2025 · NCT05270213

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, New Orleans
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Ap rekriteFaz 1/2
  • Ochsner/MD Anderson Cancer Center, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou Oct 24, 2025 · NCT06228326

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan New Orleans

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.